Subjective Experiences of Antipsychotic Treatment: A Comparison of First- and Second-generation Medications among Patients with Schizophrenia
Journal Title: International Neuropsychiatric Disease Journal - Year 2016, Vol 7, Issue 1
Abstract
Aims: The patient’s perspective of antipsychotic treatment has been a relatively neglected area of research. Whether subjective experiences of antipsychotic treatment are better among patients on second-generation antipsychotics (SGAs), than those on first-generation antipsychotics (FGAs) has also evoked some controversy. This study attempted a longitudinal comparison of attitudes toward treatment, subjective well-being and quality of life (QOL) between patients on SGAs and FGAs. Socio-demographic and clinical correlates of these subjective experiences were also examined. Methodology: Standardised ratings of insight, psychopathology, side-effects, attitudes, subjective well-being and QOL were carried out among 40 patients with schizophrenia on SGAs and 30 on FGAs, over a 6-month period. Results: Both groups were similar in the first 3-month period, apart from the slightly greater severity of illness in the FGA group. Differences in symptom-severity and side-effects emerged between the groups over the course of follow-up. Moreover, as the study progressed, differences also became apparent in subjective experiences; patients on SGAs had significantly better attitudes, subjective well-being and QOL than those on FGAs. However, differences between individual SGAs (olanzapine and risperidone) on these indices were minimal. The three indices of subjective experience were highly correlated with each other. Older age, being employed, greater insight, lower symptom-severity and the absence of side-effects demonstrated significant positive associations with different aspects of subjective experiences. Conclusions: Patients on SGAs had a more favourable profile of subjective experiences with treatment than those on FGAs. These differences seemed to be determined mainly by differences in symptom-severity and side-effects.
Authors and Affiliations
Subho Chakrabarti, Nisha Warikoo, Sandeep Grover
Keywords
Related Articles
- EP ID EP241847
- DOI 10.9734/INDJ/2016/24769
- Views 99
- Downloads 0
Mental Health Issues in Multiple Sclerosis Patients and Healthy Controls and Their Association with Disease Related Factors
Purpose: To investigate the mental health problems of multiple sclerosis (MS) patients, and the relationship between mental health, MS variables and disability status. Methods: The sample consisted of 80 participants, 4...
Roles of PI3K/AKT/PTEN Pathway in the Pathogenesis of Parkinson’s Disease and the Neuropsychiatric Symptoms
Parkinson's disease is a neurodegenerative disorder associated with loss of dopaminergic neurons in substantianigra caused by severe neuro-degeneration, which is the second most common neurodegenerative disorder after Al...
Medication Related Factors of Adherence and Attitude to Medication among Outpatients with Bipolar Disorder in Uyo, South-South Nigeria
A high level of medication adherence is required for effective treatment of bipolar disorder due to the chronic progressive nature of the illness requiring maintenance treatment. Aims: This study was conducted to determ...
Can Sonography Replace Electromyography and Nerve Conduction Velocity in Carpal Tunnel Syndrome?
Purpose of the Study: To justify the efficacy of the ultrasonography (US) in the diagnosis of carpal tunnel syndrome (CTS) in the postoperative follow-up in comparison to electrodiagnostic tests [electromyography (EMG) a...
Influence of Psychotropic Drugs upon Neuropsychological Test Performance
Commonly used psychotropic medications are widely presumed to have deleterious effects on neuropsychological test performance. However, given the special difficulties of neuropsychological assessment with psychiatric pop...